Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6954762 | 0.91 | MPO (0.48) | CTSSSMN1; SMN2NPC1RAB9ANFKB1 | |
| SCHEMBL6952897 | 0.91 | ALDH1A1 (0.43) | CTSSPTGS2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL6954596 | 0.90 | RAB9A (0.53) | CTSSSMN1; SMN2NPC1RAB9ANFKB1 | |
| SCHEMBL6959060 | 0.88 | ALDH1A1 (0.48) | CTSSSMN1; SMN2CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL6961534 | 0.86 | PTGS2 (0.48) | PTGS2SMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL6953495 | 0.85 | CNR1 (0.49) | CTSSSMN1; SMN2NPC1RAB9ANFKB1 | |
| SCHEMBL6959624 | 0.85 | MPO (0.51) | SMN1; SMN2NPC1RAB9ALMNAMAPT | |
| SCHEMBL6958429 | 0.84 | POLB (0.45) | CTSSSMN1; SMN2NPC1RAB9ANFKB1 | |
| SCHEMBL6958685 | 0.84 | GCGR (0.45) | CTSSSMN1; SMN2NPC1RAB9ANFKB1 | |
| SCHEMBL6965216 | 0.82 | THRB (0.46) | CTSSSMN1; SMN2NPC1RAB9ANFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0540143-B1 | Compounds and methods for inhibition of HIV and related viruses | MEDIVIR AB (SE) | 2003-02-05 | — | — | EP | disclosed |
| US-5714503-A | Compounds and methods for inhibition of HIV and related viruses | MEDIVIR AB (SE) | 1998-02-03 | — | — | US | disclosed |
| US-5593993-A | VIRICIDES FOR HTLV TREATMENT OF AIDS | MEDIVIR AB (SE) | 1997-01-14 | — | — | US | disclosed |
| EP-0540143-A2 | Compounds and methods for inhibition of HIV and related viruses | Medivir Aktiebolag (SE) | 1993-05-05 | — | — | EP | disclosed |
| WO-1993003022-A1 | COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES | MEDIVIR AB (SE) | 1993-02-18 | — | — | WO | disclosed |